Susquehanna International Group’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$520K	Sell	116,297 -8,678	-7%	-$40.4K	﹤0.01%	9568
2025 Q4	$687K	Buy	124,975 +103,233	+475%	+$501K	﹤0.01%	8068
2025 Q3	$71.1K	Sell	21,742 -190,830	-90%	-$540K	﹤0.01%	11734
2025 Q2	$491K	Sell	212,572 -14,900	-7%	-$32.4K	﹤0.01%	9213
2025 Q1	$316K	Buy	227,472 +85,009	+60%	+$142K	﹤0.01%	9954
2024 Q4	$246K	Sell	142,463 -34,029	-19%	-$70.6K	﹤0.01%	10246
2024 Q3	$355K	Buy	176,492 +47,292	+37%	+$104K	﹤0.01%	9241
2024 Q2	$289K	Sell	129,200 -1,180,427	-90%	-$3.44M	﹤0.01%	9525
2024 Q1	$3.76M	Sell	1,309,627 -118,519	-8%	-$247K	﹤0.01%	4113
2023 Q4	$2.53M	Buy	1,428,146 +1,225,529	+605%	+$2.44M	﹤0.01%	4883
2023 Q3	$640K	Buy	+202,617	New	+$378K	﹤0.01%	7654
2023 Q2	–	Sell	-100,044	Closed	-$79.8K	–	13160
2023 Q1	$79.8K	Sell	100,044 -60,680	-38%	-$78.4K	﹤0.01%	11433
2022 Q4	$363K	Buy	+160,724	New	+$325K	﹤0.01%	8641
2022 Q3	–	Sell	-21,163	Closed	-$76.8K	–	14140
2022 Q2	$79K	Buy	+21,163	New	+$84K	﹤0.01%	11679